Risk Assessment of PSA Recurrent Prostate Cancer

As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]